Cospharm Speciality Ingredients Profile
Key Indicators
- Authorised Capital ₹ 2.25 Cr
as on 16-07-2024
- Paid Up Capital ₹ 2.25 Cr
as on 16-07-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.41 Cr
as on 16-07-2024
- Revenue 260.84%
(FY 2023)
- Profit 85.13%
(FY 2023)
- Ebitda 783.66%
(FY 2023)
- Net Worth 12.24%
(FY 2023)
- Total Assets 3.73%
(FY 2023)
About Cospharm Speciality Ingredients
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.25 Cr and a paid-up capital of Rs 2.25 Cr.
The company currently has active open charges totaling ₹13.41 Cr.
Sandesh Malabari and Shailesh Patel serve as directors at the Company.
- CIN/LLPIN
U24304PN2018PTC176594
- Company No.
176594
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 May 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Cospharm Speciality Ingredients?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandesh Malabari  | Additional Director | 08-Mar-2023 | Current |
| Shailesh Patel | Additional Director | 21-Sep-2023 | Current |
Financial Performance of Cospharm Speciality Ingredients.
Cospharm Speciality Ingredients Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 260.84% increase. The company also saw a substantial improvement in profitability, with a 85.13% increase in profit. The company's net worth Soared by an impressive increase of 12.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cospharm Speciality Ingredients?
In 2023, Cospharm Speciality Ingredients had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Mar 2023 | ₹1.50 Cr | Open |
Others Creation Date: 02 Feb 2022 | ₹2.00 Cr | Open |
Others Creation Date: 30 Jun 2021 | ₹0.05 M | Open |
How Many Employees Work at Cospharm Speciality Ingredients?
Unlock and access historical data on people associated with Cospharm Speciality Ingredients, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cospharm Speciality Ingredients, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cospharm Speciality Ingredients's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
